Published in Am J Trop Med Hyg on March 01, 2003
Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med (2012) 2.29
Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in Brazilian children. Trans R Soc Trop Med Hyg (2008) 1.30
Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J Parasitol (2008) 1.16
Human immune responses in cryptosporidiosis. Future Microbiol (2010) 1.10
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J Infect Dis (2008) 0.99
Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun (2007) 0.93
Cryptosporidium infection impairs growth and muscular protein synthesis in suckling rats. Parasitol Res (2005) 0.83
High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun (2006) 0.82
Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans. Eur J Clin Microbiol Infect Dis (2011) 0.82
Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen. Clin Vaccine Immunol (2010) 0.80
Environmental Enteric Dysfunction in Children. J Pediatr Gastroenterol Nutr (2016) 0.80
Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality. PLoS Negl Trop Dis (2016) 0.75
Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii. Int J Nanomedicine (2015) 0.75
Delivery of Parasite Cdg7_Flc_0990 RNA Transcript into Intestinal Epithelial Cells during Cryptosporidium parvum Infection Suppresses Host Cell Gene Transcription through Epigenetic Mechanisms. Cell Microbiol (2017) 0.75
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ (2003) 11.82
Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol (2007) 5.45
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS (2005) 5.08
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Enteric infections, diarrhea, and their impact on function and development. J Clin Invest (2008) 3.23
Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol (2013) 2.96
Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev (2008) 2.84
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet (2008) 2.79
Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care (2005) 2.64
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med (2005) 2.58
Clinical practice. Acute infectious diarrhea. N Engl J Med (2004) 2.47
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.43
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol (2007) 2.37
Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr (2003) 2.33
Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol (2005) 2.27
Intestinal barrier function and weight gain in malnourished children taking glutamine supplemented enteral formula. J Pediatr Gastroenterol Nutr (2005) 2.25
Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg (2002) 2.22
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am (2006) 2.05
Neuroendoscopic diagnosis of central nervous system histoplasmosis with basilar arachnoiditis. World Neurosurg (2011) 2.05
Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis (2012) 1.95
Enteroaggregative Escherichia coli (EAEC) impairs growth while malnutrition worsens EAEC infection: a novel murine model of the infection malnutrition cycle. J Infect Dis (2010) 1.90
Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg (2012) 1.83
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii. ACS Med Chem Lett (2010) 1.82
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. AIDS (2004) 1.74
Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis (2005) 1.72
Cryptosporidiosis: epidemiology and impact. Microbes Infect (2002) 1.71
Early childhood diarrhea predicts impaired school performance. Pediatr Infect Dis J (2006) 1.71
Updating the DALYs for diarrhoeal disease. Trends Parasitol (2002) 1.66
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev (2016) 1.66
Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis (2004) 1.65
Childhood stunting: measuring and stemming the staggering costs of inadequate water and sanitation. Lancet (2004) 1.56
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol (2006) 1.54
The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol (2012) 1.53
A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis (2002) 1.49
Magnitude and impact of diarrheal diseases. Arch Med Res (2002) 1.49
Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg (2006) 1.49
A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect Immun (2008) 1.47
Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med (2014) 1.47
Reducing stunting among children: the potential contribution of diagnostics. Nature (2006) 1.44
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg (2009) 1.41
Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect Immun (2008) 1.41
Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology (2010) 1.41
APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil. Pediatr Res (2004) 1.39
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis (2006) 1.38
Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull (2013) 1.38
Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of toll-like receptor 5. J Biol Chem (2002) 1.37
Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg (2006) 1.35
Cholera--still teaching hard lessons. N Engl J Med (2006) 1.35
American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area. J Pediatr (Rio J) (2005) 1.33
Wasting is associated with stunting in early childhood. J Nutr (2012) 1.33
Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis (2002) 1.32
Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg (2010) 1.31
Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in Brazilian children. Trans R Soc Trop Med Hyg (2008) 1.30
Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg (2005) 1.30
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
Severe Rift Valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hyg (2010) 1.29
Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis (2010) 1.29
A lion in our village--the unconscionable tragedy of cholera in Africa. N Engl J Med (2009) 1.27
Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl Trop Dis (2009) 1.26
Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction. Am J Trop Med Hyg (2007) 1.25
HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep (2002) 1.25
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. J Infect Dis (2013) 1.23
Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes. J Med Microbiol (2006) 1.23
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis (2009) 1.23
The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology (2008) 1.23
Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol (2007) 1.23
Diarrhea in early childhood: short-term association with weight and long-term association with length. Am J Epidemiol (2013) 1.22
Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. J Infect Dis (2002) 1.22
Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology (2012) 1.20
Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) (2011) 1.19
Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab (2002) 1.18
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy (2005) 1.18
Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol (2004) 1.18
Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun (2006) 1.18
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. Clin Infect Dis (2007) 1.17
Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Am J Trop Med Hyg (2005) 1.17
Cryptosporidiosis. Curr Opin Infect Dis (2002) 1.17
Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16
Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J Parasitol (2008) 1.16
Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol (2009) 1.14
Limitations in verbal fluency following heavy burdens of early childhood diarrhea in Brazilian shantytown children. Child Neuropsychol (2005) 1.14
Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development. Med Hypotheses (2006) 1.14